BeStock  

丹纳赫 DHR

美股市值排名 #119诊断与研究
$230.25 +$3.91 (+1.73%)
休市 · Nov 6, 9:40 pm ET · 最新盘后价 $230.25 0.00%
开盘$222.96
昨收$226.34
当日区间$222.96 – $230.66
成交量4.06M
市值$161.99B
市盈率(TTM)37.7
股息率0.66%

基本面

最新报告季度:Q3, ended Sep 2026

营收$6.55B+8.3% YoY
营业利润$1.25B+7.9% YoY
净利润$1.24B+36.0% YoY
摊薄每股收益$1.75+37.8% YoY
自由现金流$1.63B+19.1% YoY
经营现金流$1.89B

营收,近8个季度

$6.5BDec '24$5.7BMar '25$5.9BJun '25$6.1BSep '25$6.8BDec '25$6.0BMar '26$6.3BJun '26$6.6BSep '26

净利润,近8个季度

$1.1BDec '24$954.0MMar '25$555.0MJun '25$908.0MSep '25$1.2BDec '25$1.0BMar '26$870.0MJun '26$1.2BSep '26

各季度摊薄每股收益

1.49Dec '241.32Mar '250.77Jun '251.27Sep '251.68Dec '251.45Mar '261.23Jun '261.75Sep '26

各季度自由现金流

$1.5BDec '24$1.1BMar '25$1.1BJun '25$1.4BSep '25$1.7BDec '25$1.1BMar '26$1.3BJun '26$1.6BSep '26

年度营收

$22.3BFY20$24.8BFY21$26.6BFY22$23.9BFY23$23.9BFY24$24.6BFY25

盈利能力与资产负债表

毛利率58.6%
营业利润率20.4%
净利率16.9%
净资产收益率8.3%
资产收益率5.0%
投入资本回报率6.1%
流动比率1.63
负债/资产比率42.5%
现金及投资$5.68B
总负债$26.48B
净现金(净负债)-$20.80B
自由现金流/营收22.4%

营收构成

2026/Q3 季度

按业务线

  • Diagnostics$2.88B 44.0%
  • Life sciences$1.87B 28.5%
  • Biotechnology$1.81B 27.6%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $6.55B $6.27B $5.95B $24.57B $6.84B
营业总收入 $6.55B $6.27B $5.95B $24.57B $6.84B
营业成本 $2.72B $2.65B $2.36B $10.05B $2.87B
毛利润 $3.84B $3.61B $3.59B $14.52B $3.97B
营业费用 $2.59B $2.48B $2.25B $9.83B $2.46B
销售及管理费用 $2.16B $2.07B $1.86B $8.24B $2.03B
研发费用 $433.00M $412.00M $387.00M $1.60B $438.00M
营业利润 $1.25B $1.13B $1.34B $4.69B $1.50B
非经营性利息净收入(支出) -$104.00M -$46.00M -$36.00M -$235.00M -$42.00M
非经营性利息收入 $31.00M $61.00M $27.00M $30.00M $13.00M
非经营性利息支出 $135.00M $107.00M $63.00M $265.00M $55.00M
其他收入(支出) -$9.00M -$3.00M -$73.00M -$222.00M -$87.00M
证券出售收益 -$13.00M -$7.00M -$77.00M -$248.00M -$99.00M
特殊收益(费用) $0.00 $0.00 $0.00 $20.00M $11.00M
-业务出售收益 $0.00 $0.00 $0.00 $9.00M $0.00
其他非经营性收入(支出) $4.00M $4.00M $4.00M $6.00M $1.00M
税前利润 $1.13B $1.08B $1.24B $4.23B $1.37B
税费 -$75.00M $208.00M $206.00M $633.00M $190.00M
净利润 $1.24B $870.00M $1.03B $3.61B $1.20B
持续经营利润 $1.21B $870.00M $1.03B $3.60B $1.18B
终止经营净利润 $28.00M – – $14.00M $14.00M
归属母公司净利润 $1.24B $870.00M $1.03B $3.61B $1.20B
归属普通股股东净利润 $1.24B $870.00M $1.03B $3.61B $1.20B
基本每股收益 $1.75 $1.23 $1.45 $5.07 $1.69
摊薄每股收益 $1.75 $1.23 $1.45 $5.05 $1.68
每股股息 $0.40 $0.40 $0.40 $1.28 $0.32
-固定资产出售收益 – – – $11.00M –

资产负债表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
总资产 $93.28B $92.37B $83.54B $83.46B $83.46B
流动资产合计 $14.79B $13.38B $13.94B $12.76B $12.76B
现金及现金等价物与短期投资 $5.68B $4.35B $5.70B $4.62B $4.62B
-现金及现金等价物 $5.68B $4.35B $5.70B $4.62B $4.62B
应收款 $4.13B $3.97B $3.82B $3.91B $3.91B
-应收账款 $4.13B $3.97B $3.82B $3.91B $3.91B
存货 $3.13B $3.26B $2.61B $2.49B $2.49B
其他流动资产 $1.85B $1.81B $1.81B $1.74B $1.74B
非流动资产合计 $78.49B $78.99B $69.61B $70.71B $70.71B
固定资产净值 $5.77B $5.83B $5.47B $5.53B $5.53B
-固定资产原值 $10.82B $10.74B $10.30B $10.30B $10.30B
-累计折旧 -$5.04B -$4.92B -$4.83B -$4.77B -$4.77B
商誉及其他无形资产 $68.37B $68.77B $59.93B $60.97B $60.97B
-商誉 $47.32B $47.41B $42.77B $43.15B $43.15B
-其他无形资产 $21.05B $21.36B $17.17B $17.82B $17.82B
其他非流动资产 $4.35B $4.39B $4.21B $4.21B $4.21B
负债合计 $39.65B $39.78B $30.59B $30.92B $30.92B
流动负债合计 $9.05B $8.11B $7.46B $6.81B $6.81B
应付款 $1.74B $1.82B $1.79B $2.45B $2.45B
-应付账款 $1.74B $1.82B $1.79B $1.84B $1.84B
一年内应计费用 $5.21B $4.87B $4.75B – –
短期债务及融资租赁负债 $2.09B $1.41B $923.00M $201.00M $201.00M
-一年内到期债务 $2.09B $1.41B $923.00M $2.00M $2.00M
非流动负债合计 $30.60B $31.67B $23.13B $24.12B $24.12B
长期债务及融资租赁负债 $24.39B $25.15B $17.56B $19.50B $19.50B
-长期债务 $24.39B $25.15B $17.56B $18.42B $18.42B
其他非流动负债 $6.21B $6.52B $5.57B $184.00M $184.00M
股东权益合计 $53.63B $52.59B $52.96B $52.54B $52.54B
股东权益 $53.62B $52.58B $52.95B $52.53B $52.53B
股本 $9.00M $9.00M $9.00M $9.00M $9.00M
-普通股 $9.00M $9.00M $9.00M $9.00M $9.00M
资本公积 $17.63B $17.46B $17.30B $17.19B $17.19B
留存收益 $49.18B $48.23B $47.64B $46.89B $46.89B
减:库存股 $12.33B $12.32B $11.41B $11.35B $11.35B
不影响留存收益的损益 -$865.00M -$795.00M -$593.00M -$207.00M -$207.00M
少数股东权益 $12.00M $11.00M $8.00M $7.00M $7.00M
-应付税款合计 – – – $532.00M $532.00M
-其他应付款 – – – $75.00M $75.00M
-一年内到期融资租赁负债 – – – $199.00M $199.00M
一年内预提费用 – – – $187.00M $187.00M
一年内递延负债 – – – $1.35B $1.35B
其他流动负债 – – – $1.37B $1.37B
长期应付账款及其他应付款 – – – $3.23B $3.23B
-长期融资租赁负债 – – – $1.08B $1.08B
衍生产品负债 – – – $0.00 $0.00
非流动负债 – – – $7.00M $7.00M
一年以上递延负债 – – – $231.00M $231.00M
员工福利 – – – $968.00M $968.00M

现金流量表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
经营活动现金流 $1.89B $1.53B $1.32B $6.42B $2.12B
持续经营经营活动现金流净额 $1.89B $1.53B $1.32B $6.42B $2.12B
持续经营净利润 $1.21B $870.00M $1.03B $3.60B $1.18B
持续经营损益 $13.00M $7.00M $77.00M $228.00M $88.00M
折旧、折耗与摊销 $721.00M $659.00M $627.00M $2.45B $623.00M
其他非现金项目 $84.00M – – – –
营运资金变动 -$306.00M -$141.00M -$469.00M -$719.00M $146.00M
-应收款变动 -$160.00M $71.00M $66.00M -$216.00M -$151.00M
-存货变动 -$51.00M -$46.00M -$132.00M -$58.00M $184.00M
-预付资产变动 -$44.00M $121.00M -$40.00M -$55.00M -$2.00M
-应付账款及应计费用变动 -$51.00M -$287.00M -$363.00M $50.00M $555.00M
投资活动现金流净额 -$300.00M -$10.15B -$249.00M -$1.20B -$384.00M
持续经营投资活动现金流净额 -$300.00M -$10.15B -$249.00M -$1.20B -$384.00M
固定资产购置及出售净额 -$254.00M -$269.00M -$237.00M -$1.12B -$348.00M
业务购买及出售净额 -$38.00M -$9.84B $0.00 $9.00M $0.00
投资购置及出售净额 -$19.00M -$47.00M -$20.00M -$115.00M -$48.00M
其他投资变动净额 $11.00M $12.00M $8.00M $33.00M $12.00M
筹资活动现金流 -$262.00M $7.27B $46.00M -$2.96B $1.32B
持续经营筹资活动现金流净额 -$262.00M $7.27B $46.00M -$2.96B $1.32B
债务发行及偿还净额 -$7.00M $8.49B $309.00M $1.05B $1.52B
普通股发行净额 $0.00 -$894.00M $0.00 -$3.00B $85.00M
已付现金股利 -$281.00M -$283.00M -$226.00M -$878.00M -$226.00M
股票期权行使所得 $35.00M $8.00M -$9.00M – –
其他筹资费用净额 -$9.00M -$43.00M -$28.00M -$125.00M -$17.00M
期末现金余额 $5.68B $4.35B $5.70B $4.62B $4.62B
现金净变动 $1.32B -$1.34B $1.12B $2.26B $3.06B
期初现金余额 $4.35B $5.70B $4.62B $2.08B $1.53B
汇率变动影响 $10.00M -$13.00M -$33.00M $278.00M $32.00M
自由现金流 $1.63B $1.27B $1.09B $5.26B $1.75B
-其他营运资金变动 – – – -$440.00M –
终止经营经营活动现金流 – – – $0.00 –

讨论区

暂无评论——快来第一个聊聊 DHR。

发表评论

Scroll to Top